Around 99% of doses that are administered on the continent are imported. To address this problem, vaccine manufacturing facilities in Senegal, Rwanda, and South Africa are showing interest in a technology that reduces production costs and gets around patent barriers
Massachusetts, US-based biotechnology and pharmaceuticals firm Moderna is set to build a manufacturing facility in Kenya to produce mRNA vaccines, including those for COVID-19. The facility is set to be Moderna’s first manufacturing plant in Africa with the company expected to invest $500-million in the construction of the facility in order to supply as many […]